Frank Ziovas 22 December 2020
Anaphylaxis in UK Following COVID-19 Vaccination
December 8, 2020 –UK initiated vaccination with Pfizer-BioNTechCOVID-19 vaccine
December 9 –UK authorities confirmed 2 cases of anaphylaxis after vaccination
Prescribing information for both Pfizer-BioNTechand ModernaCOVID-19 vaccines contains information on anaphylaxis
- Severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine is a contraindication to vaccination
- Appropriate medical treatment used to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of the vaccine
Appropriate medical treatment used to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of the vaccine
- December 12 –CDC published clinical considerations for use of Pfizer-BioNTechCOVID-19 vaccine
- Included guidance on contraindications and precautions (https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/clinical-considerations.html#contraindications-precautions)
Download the entire presentation below:
Please share this information